Skip to content

Asset Apollo

by Philips Medical Systems (Cleveland), Inc.

510(k) K971884

Asset Apollo is a medical device (FDA Class II; FDA product code LNH, System, Nuclear Magnetic Resonance Imaging) made by Philips Medical Systems (Cleveland), Inc., cleared under FDA 510(k) K971884 on 20 Aug 1997, active as of 22 Oct 2026. One FDA recall is linked to it.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

1 closed

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK971884 Date20 Aug 1997ClearedStatusActive

Official records

From the FDA record

Received by the FDA
22 May 1997
FDA decision
20 Aug 1997 (Substantially Equivalent)
FDA review time
90 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K971884 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Recalls

1 recall · FDA

    • Terminated Z-0033-2014 FDA Class II initiated 7 Aug 2013

    There is a potential for water to collect in the vent pipe elbow in the magnet venting system. Water may freeze, blocking the venting system.

Timeline

2 dated events

  1. Cleared FDA 510(k) K971884
  2. Recall initiated FDA recalls Z-0033-2014

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
LNH
Device class
Class II
Regulation
21 CFR Part 892.1000
Advisory committee
Radiology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code LNH (System, Nuclear Magnetic Resonance Imaging).

Other devices from Philips Medical Systems (Cleveland), Inc.

See all devices from Philips Medical Systems (Cleveland), Inc. →